Oaktree Acquisition Corp. III Life Sciences (OACC) Net Cash Flow (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Net Cash Flow readings, the most recent being -$158035.0 for Q1 2026.
- Quarterly Net Cash Flow fell 109.15% to -$158035.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$254553.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $77921.0 for FY2025, 94.26% down from the prior year.
- Net Cash Flow hit -$158035.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from $106124.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $106124.0 in Q4 2025 and bottomed at -$158035.0 in Q1 2026.